Back

Assemblon expands at Harwell Campus

Assemblon Ltd, the custom oligonucleotide synthesis and chemistry company founded by Professor Tom Brown, Dr Daniel Singleton and Dr Richard Cunningham, has moved into new laboratories at Harwell Campus, marking a significant expansion little more than a year after the company was founded.

The move increases Assemblon’s synthesis and purification capacity to meet growing demand from biotechnology, pharmaceutical and academic organisations around the world.

The company produces custom strands of DNA and RNA, known as oligonucleotides, which are used in the development of medical diagnostics and new treatments. Its new laboratories, located in the Research Complex next to Diamond Light Source, the UK’s national synchrotron, are equipped with eight fume hoods, synthetic chemistry facilities, high-throughput DNA and RNA synthesis systems, and HPLC purification platforms. Additional synthesisers are also being commissioned.

The expanded facilities will allow Assemblon to handle higher volumes and more complex projects, while retaining the direct, chemist-led service that underpins its approach.

Co-founder Dr Richard Cunningham said: “The move gives us room we didn’t have, and the equipment to make the most of it. Demand has grown quickly, particularly for heavily modified and conjugated oligonucleotides. What doesn’t change is how we work: customers will still deal directly with our nucleic acid chemistry and applications experts.”

Co-founder Dr Daniel Singleton added: “We’re seeing strong interest from biotech, pharma and academic groups around the world. The expansion means we can take on more complex projects and support higher-throughput synthesis.”

Assemblon produces DNA, RNA and chemically modified oligonucleotides for diagnostic and therapeutic applications. Its capabilities include antisense oligonucleotides (ASOs), splice-switching oligonucleotides (SSOs), siRNAs, miRNAs, conjugates, duplexes and aptamers.

Every product undergoes identity confirmation by UPLC-MS before release, and the company is certified to ISO 9001:2015. Assemblon also provides standalone UPLC-MS analysis services, including identity confirmation, purity assessment and duplex characterisation.

The company regularly publishes technical articles covering oligonucleotide chemistry, modification, purification and analysis. Find out more at www.assemblon.co.uk.